Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Saliva Test Rapidly Identifies Paracetamol Overdose

By LabMedica International staff writers
Posted on 06 Dec 2024

Paracetamol is the most widely used medication worldwide, and its easy availability contributes to its frequent misuse and overdose. More...

Overdosing on paracetamol can lead to liver toxicity, requiring hospitalization. Without prompt treatment, it can result in severe consequences such as liver failure, the need for a transplant, or even death. N-acetylcysteine (NAC) is the standard treatment for paracetamol overdose and is effective in preventing acute liver injury (ALI), but it must be administered within 8 hours to be most effective. Quick and accurate paracetamol quantification is critical in guiding overdose treatment. Existing methods typically involve invasive sampling and lengthy processing times. Now, researchers have introduced a groundbreaking technique that allows for rapidly detecting paracetamol levels from saliva.

In a study published in the journal BMC Medicine, a team led by the University of Liverpool (Liverpool, UK) demonstrated the clinical validity of a novel Mass Spectrometry-based technique that tests a small drop of saliva on paper for paracetamol levels. This technique, called Paper-Arrow Mass Spectrometry (PA-MS) was found to offer superior analytical performance with reduced time, resources, and clinical involvement compared to traditional methods.

The research team tested the technique using both saliva and plasma samples from volunteers who had taken paracetamol. They found saliva to be the preferred sample for paracetamol detection. The PA-MS method proved reliable for detecting paracetamol in stimulated saliva, offering a valuable tool for making timely treatment decisions. For the first time, the study also identified differences in paracetamol concentrations between resting and stimulated saliva, underscoring the importance of standardizing saliva collection methods. This breakthrough marks a significant step forward in the development of rapid and convenient saliva-based diagnostic tools.

“This study demonstrates successful testing of the new PA-MS test in a clinical environment and lays the foundation for advancing point-of-care testing across emergency and routine clinical settings,” said Dr. Simon Maher, an expert in Mass Spectrometry Technologies with the University of Liverpool’s Department of Electrical Engineering and Electronics. “This innovation represents a significant step forward in ambient ionization mass spectrometry techniques, with the potential for broad application in clinical diagnostics.”


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.